ロード中...
Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats
Cebranopadol is a novel agonist of nociceptin/orphanin FQ peptide (NOP) and opioid receptors with analgesic properties that is being evaluated in clinical Phase 2 and Phase 3 trials for the treatment of chronic and acute pain. Recent evidence indicates that the combination of opioid and NOP receptor...
保存先:
| 出版年: | J Pharmacol Exp Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5539589/ https://ncbi.nlm.nih.gov/pubmed/28645915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.117.241042 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|